We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue
RANDOX LABORATORIES

Download Mobile App




In Other News

Image: Leica Biosystems and CellCarta have expanded a coordinated companion diagnostic (CDx) development model to biopharma sponsors worldwide

Global Framework Integrates Digital Pathology for Companion Diagnostic Development

Leica Biosystems and CellCarta have expanded a coordinated CDx development model to biopharma sponsors worldwide. Read more
01 Jun 2026 | Industry
Image: NHS-Galleri Trial: Percent difference in Stage IV cancers (Photo courtesy of GRAIL)

GRAIL Presents Full Results from NHS-Galleri Trial at ASCO 2026

GRAIL reported NHS-Galleri trial findings at ASCO 2026 showing fewer stage IV diagnoses despite missing the combined stage III–IV endpoint. Read more
01 Jun 2026 | Industry
Image: The updated CRC screening guidance adds a stool RNA test and an updated stool DNA test to the menu of preferred options (image credit: Adobe Stock)

Updated Guidance Prioritizes Stool-Based Colorectal Cancer Screening Tests

Guidelines recommend stool RNA and updated stool DNA tests for CRC screening, limiting blood tests due to lower sensitivity. Read more
29 May 2026 | Molecular Diagnostics
Image: The new assays target the nucleoprotein (NP) and VP35 regions of the ebolavirus (image credit: 123RF)

Digital PCR Assays Support Surveillance of Bundibugyo Ebolavirus Outbreak

A new dPCR assay set enables rapid, sensitive Bundibugyo ebolavirus detection for research and wastewater surveillance. Read more
29 May 2026 | Molecular Diagnostics
Image: New urine test provides a simple way to screen for autism in children (Photo courtesy of Andy DeLisle/ASU Knowledge Enterprise)

Urine-Based Test Shows Promise for Autism Screening in Children

A new urine test measuring 17 gut microbe-derived metabolites distinguished children with autism with high accuracy. Read more
28 May 2026 | Clinical Chem.
Image: Graphical Abstract (Microbiome Research Reports: DOI:10.20517/mrr.2025.96)

Gut Microbiome Signatures Help Identify Risk of IBD Progression

New findings show gut microbiome cluster types are linked to IBD severity and progression risk, enabling improved stratification. Read more
28 May 2026 | Microbiology
Image: Work inside the labs at the University of Southampton Centre for Cancer Immunology (Photo courtesy of University of Southampton)

Lung Cancer Study Reveals Cellular Program Behind Therapy Resistance

New findings reveal that lung cancer cells can become harder to treat by reactivating an early development process. Read more
28 May 2026 | BioResearch
Image: New findings show that mailed at-home stool tests can substantially increase screening across diverse racial and ethnic groups (image credit: Adobe Stock)

Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps

New data show mailed FIT boosts colorectal cancer screening across racial groups, but colonoscopy follow-up gaps persist. Read more
28 May 2026 | Technology
Image: Together, the companies aim to streamline laboratory workflows and provide a fast, accurate “DNA-to-result” process using scalable nanopore sequencing

Werfen and Oxford Nanopore Collaborate on Transplant Assay Development

The collaboration combines Werfen’s validated transplant assays with Oxford Nanopore’s sequencing technology. Read more
28 May 2026 | Industry
Image: The panel combines biomarker-based diagnostics with advanced digital algorithms to enable noninvasive assessment using routinely available clinical data (Photo courtesy of Adobe Stock)

Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance

A new algorithm-driven liver panel enables earlier noninvasive fibrosis risk stratification and HCC assessment from routine labs. Read more
28 May 2026 | Technology
Image: The Avantect Pancreatic Cancer Test enables early detection of pancreatic cancer in high-risk patients (Photo courtesy of ClearNote Health)

ClearNote Health to Present Pancreatic Cancer Blood Test Data at ASCO 2026

A new multimodal blood test detects early pancreatic cancer with 76.8% stage I-II sensitivity and 97.5% specificity. Read more
28 May 2026 | Industry
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

A new proteomic blood test helps predict treatment response and progression in NSCLC. Read more
28 May 2026 | Molecular Diagnostics
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

New findings highlight the role of MRD detection in breast cancer management, showing that ctDNA monitoring can predict progression up to years earlier. Read more
27 May 2026 | Molecular Diagnostics
Image: MCD tests are designed to detect multiple cancers from a single blood sample, but the statements note that evaluating these assays is far more complex than assessing single-cancer tests (image credit: Adobe Stock)

Position Statements Outline Evidence Standards for Multi-Cancer Detection Tests

New position statements outline evidence standards for assessing emerging multi-cancer detection tests. Read more
27 May 2026 | Molecular Diagnostics

Channels

Clinical Chemistry

view channel
Blood-Based Sensor Detects Early Signs of Alzheimer’s and Parkinson’s
Urine-Based Alzheimer’s Test Receives FDA Breakthrough Device Designation
Fluid Biomarker Improves Diagnosis and Monitoring of Primary CNS Lymphoma
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
New RNA Origami Method Supports Faster Targeted Testing for Repeat Expansion Dis...
FDA Approves Expanded Liquid Biopsy Panel for Advanced Cancer Profiling
Microbial Saliva Test Could Help Triage Esophageal Cancer Risk
Image: Physicians currently use the Demicco score, which considers patient age, tumor size, and microscopic appearance, to estimate SFT aggressiveness, but uncertainty can remain about which patients need closer surveillance (image credit: Shutterstock)

Gene Fusion Patterns May Flag High Risk Solitary Fibrous Tumors

Solitary fibrous tumor (SFT) is a rare subtype of sarcoma, a cancer that develops in connective tissues such as fat, muscle, blood vessels, and fibrous tissue. SFTs most commonly arise in the chest cavity... Read more

Hematology

view channel
Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Blood Test Enables Early Detection of Multiple Myeloma Relapse
Image: The study’s findings may help identify iron deficiency earlier in children aged 5 to 14 years.(Photo courtesy of iStock)

Higher Ferritin Threshold May Improve Iron Deficiency Detection in Children

Iron deficiency in school-age children can affect brain development, learning, growth, and physical performance, yet early deficiency may be missed when screening focuses mainly on anemia.... Read more

Immunology

view channel
Simple Blood Test Could Replace Biopsies for Lung Transplant Rejection Monitorin...
Routine TB Screening Test May Reveal Immune Aging and Mortality Risk
Biomarkers and Molecular Testing Advance Precision Allergy Care
Image: Graphical Abstract (Crotts S.B., Barnes J.T., Antonetti R.M., et al. Cell Reports (2026). DOI:10.1016/j.celrep.2026.117347)

Immune Enzyme Linked to Treatment-Resistant Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) affects nearly 3 million people in the United States and its prevalence continues to rise. Medications that target tumor necrosis factor (TNF)-alpha are widely used, but... Read more

Microbiology

view channel
New AMR Assay Supports Rapid Infection Control Screening in Hospitals
Diagnostic Gaps Complicate Bundibugyo Ebola Outbreak Response in Congo
Study Finds Hidden Mpox Infections May Drive Ongoing Spread
Image: Using Diasorin’s Flex Software, laboratories can tailor target selection to seasonality, clinical presentation, current clinical guidelines, recent patient travel history, or immune status (Photo courtesy of Diasorin)

FDA-Cleared Gastrointestinal Panel Detects 24 Pathogen Targets

Clinical guidelines support testing based on patient presentation in suspected gastrointestinal infections, yet available technologies have often forced laboratories to choose between panels that are too... Read more

Pathology

view channel
Rapid AI Tool Predicts Cancer Spatial Gene Expression from Pathology Images
AI Pathology Test Receives FDA Breakthrough for Bladder Cancer Risk Stratificati...
FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more

Technology

view channel
AI Tool Automates Validation of Laboratory Software Configuration Changes
Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Di...
Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
Image: QIA Agent is an AI-powered digital assistant designed to help users plan experiments, identify suitable products, access technical information, and manage ordering through a single interface (Photo courtesy of Qiagen)

AI-Enabled Assistant Unifies Molecular Workflow Planning and Support

Clinical laboratories and research groups face increasingly complex molecular workflows and expanding technical documentation spread across multiple systems. Fragmented digital tools can slow experiment... Read more

Industry

view channel
Artera to Highlight AI-Based Cancer Risk Stratification at ASCO 2026
Natera to Present Data on MRD-Guided Cancer Care at ASCO 2026
Fujifilm Integrates Structured Reporting into Digital Pathology Workflow
Image: Canhelp‑UCa is a CE‑marked IVD molecular assay developed for the noninvasive detection and recurrence monitoring of urothelial carcinoma of the bladder and upper urinary tract (Photo courtesy of Canhelp Genomics)

New Distribution Agreement Expands Access to CE-Marked Precision Oncology Assays

Eurobio Scientific (Les Ulis, France) has signed a distribution agreement with Canhelp Genomics (Hangzhou, China) to broaden availability of the Canhelp‑UCa and Canhelp‑Origin assays. The agreement extends... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica ExpoHospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2026
WHX Labs Dubai 2025
Medica ADLM MEDLAB 2024
Medica ADLM

 

Medlab 2023
Medica AACC EUROMEDLAB Medlab 2022
MEDICA AACC ECCMID
Copyright © 2000-2026 Globetech Media. All rights reserved.
MOBILE | FULL SITE